Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lubberink

Showing results (71-80 of 242) with videos related to

Pageof 25
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2015
(15)O-Water PET Study of the Effect of Imatinib, a Selective Platelet-Derived Growth Factor Receptor Inhibitor, Versus Anakinra, an IL-1R Antagonist, on Water-Perfusable Tissue Fraction in Colorectal Cancer MetastasesMark Lubberink, Sanjeep S V Golla, My Jonasson, et al.
Current Pharmaceutical Design|November 11, 2008
Individualized treatment planning in oncology: role of PET and radiolabelled anticancer drugs in predicting tumour resistanceAstrid A M van der Veldt, Gert Luurtsema, Mark Lubberink, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 25, 2002
Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33. Implications for in vivo dosimetryAnna Orlova, Johanna Höglund, Mark Lubberink, et al.
British Journal of Anaesthesia|June 24, 2026
Hypotension and pulmonary atelectasis during general anaesthesia: a randomised crossover laboratory studyErland Östberg, Cecilia Wassberg, Mark Lubberink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2017
Studies of a Next-Generation Silicon-Photomultiplier-Based Time-of-Flight PET/CT SystemDavid F C Hsu, Ezgi Ilan, William T Peterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 19, 2011
Parametric images of myocardial viability using a single 15O-H2O PET/CT scanHendrik J Harms, Stefan de Haan, Paul Knaapen, et al.
Theranostics|July 7, 2012
Lessons on Tumour Response: Imaging during Therapy with (177)Lu-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine CarcinomaUlrike Garske, Mattias Sandström, Silvia Johansson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 26, 2025
Automated Total-Body Perfusion Imaging with <sup>15</sup>O-Water PET Using Basis Functions and Organ-Specific Model SelectionAnna Åhlström, Elin Lindström, Teemu Maaniitty, et al.
EJNMMI Research|March 24, 2020
Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancerAli Alhuseinalkhudhur, Mark Lubberink, Henrik Lindman, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 8, 2010
Coronary steal: revealing the diagnosis with quantitative cardiac PET/CTMechteld Heijne, Pieter G Raijmakers, Hendrik J Harms, et al.
Pageof 25

Showing results (71-80 of 242) with videos related to

Sort By:
Pageof 25
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2015
(15)O-Water PET Study of the Effect of Imatinib, a Selective Platelet-Derived Growth Factor Receptor Inhibitor, Versus Anakinra, an IL-1R Antagonist, on Water-Perfusable Tissue Fraction in Colorectal Cancer MetastasesMark Lubberink, Sanjeep S V Golla, My Jonasson, et al.
Current Pharmaceutical Design|November 11, 2008
Individualized treatment planning in oncology: role of PET and radiolabelled anticancer drugs in predicting tumour resistanceAstrid A M van der Veldt, Gert Luurtsema, Mark Lubberink, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 25, 2002
Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33. Implications for in vivo dosimetryAnna Orlova, Johanna Höglund, Mark Lubberink, et al.
British Journal of Anaesthesia|June 24, 2026
Hypotension and pulmonary atelectasis during general anaesthesia: a randomised crossover laboratory studyErland Östberg, Cecilia Wassberg, Mark Lubberink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2017
Studies of a Next-Generation Silicon-Photomultiplier-Based Time-of-Flight PET/CT SystemDavid F C Hsu, Ezgi Ilan, William T Peterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 19, 2011
Parametric images of myocardial viability using a single 15O-H2O PET/CT scanHendrik J Harms, Stefan de Haan, Paul Knaapen, et al.
Theranostics|July 7, 2012
Lessons on Tumour Response: Imaging during Therapy with (177)Lu-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine CarcinomaUlrike Garske, Mattias Sandström, Silvia Johansson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 26, 2025
Automated Total-Body Perfusion Imaging with <sup>15</sup>O-Water PET Using Basis Functions and Organ-Specific Model SelectionAnna Åhlström, Elin Lindström, Teemu Maaniitty, et al.
EJNMMI Research|March 24, 2020
Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancerAli Alhuseinalkhudhur, Mark Lubberink, Henrik Lindman, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 8, 2010
Coronary steal: revealing the diagnosis with quantitative cardiac PET/CTMechteld Heijne, Pieter G Raijmakers, Hendrik J Harms, et al.
Pageof 25